Crimmins, G., Polasek, T., Robb, C., Pendyala, S., Schelle, M., Jarvela, T., Cole, B., Wu, M., Joe-Nweke, K., Jesús-Díaz, D. D. (2025). First-in-human randomized placebo-controlled Phase 1 study of RPT1G, a novel hyperbolic NAMPT inhibitor for use in acute leukemias: Safety, pharmacokinetics, and pharmacodynamics in healthy volunteers. Blood. https://doi.org/10.1182/blood-2025-5044